Letter: Helicobacter pylori and metabolic syndrome‐related von Willebrand factor and plasminogen activator inhibitor‐1 activity levels for outcome prediction of advanced chronic liver disease

LINKED CONTENT This article is linked to Dominik et al papers. To view these articles, visit https://doi.org/10.1111/apt.17945 and https://doi.org/10.1111/apt.18144

Saved in:
Bibliographic Details
Published in:Alimentary pharmacology & therapeutics 2024-08, Vol.60 (4), p.540-541
Main Authors: Kountouras, Jannis, Polyzos, Stergios A., Kazakos, Evangelos, Papanikolaou, Ioannis S., Liatsos, Christos, Vardaka, Elisabeth, Tzilves, Dimitrios, Vlachaki, Efthimia
Format: Article
Language:English
Subjects:
Chronic Disease
Helicobacter Infections - complications
Helicobacter pylori
Humans
Liver Diseases
Metabolic Syndrome
Plasminogen Activator Inhibitor 1 - blood
Plasminogen activator inhibitors
Von Willebrand factor
von Willebrand Factor - metabolism
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:LINKED CONTENT This article is linked to Dominik et al papers. To view these articles, visit https://doi.org/10.1111/apt.17945 and https://doi.org/10.1111/apt.18144
ISSN:0269-2813
1365-2036
1365-2036
DOI:10.1111/apt.18066